Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
Indicators
In development
GID-IND10348
Diabetes: metformin, SGLT2 inhibitors and semaglutide (T2DM and CVD)
In development GID-IND10348
Expected publication date: TBC
Register as a stakeholder
Project information
Status:
In progress
Process:
IND
Provisional Schedule
NICE indicator consultation
01 April 2026 - 29 April 2026
Back to top